한글목차

정신건강 스크리닝 시장 규모는 예측 기간 중 12.2%의 CAGR로 추이하며, 2023년 9억 달러에서 2029년에는 18억 달러 규모로 성장할 것으로 예측됩니다.

노인 인구 증가와 이에 따른 정신장애 유병률 증가, 원격 모니터링에 대한 관심 증가는 이 시장의 성장을 가속하는 요인입니다. 반면, 편견과 제한적인 인식, 데이터 프라이버시에 대한 우려는 예측 기간 중 정신건강 검진 솔루션의 채택을 어느 정도 억제할 수 있습니다.

기술별로는 AI 기반 스크리닝 툴 부문이 예측 기간 중 가장 높은 성장을 기록할 전망 :

AI 기반 스크리닝 툴의 성장은 AI 기술의 진보와 함께 정신건강 스크리닝에서 스케일러블하고 정확한 솔루션에 대한 수요가 증가하고 있는 것에 기인하고 있습니다.

환경별로는 임상 부문이 최대 점유율을 보일 전망 :

2022년 시장에서는 임상 환경이 최대 점유율을 차지하고 있습니다. 이 부문은 인지도의 향상, 정신건강 장애의 유병률 상승, 기술의 진보, 정책 지원, 예방적 및 환자 중심 케어로의 이동에 의해 큰 성장이 전망됩니다.

연령별로는 고령자(65세 이상) 부문이 예측 기간 중 최대 성장을 보일 전망 :

고령자층에서 정신건강 스크리닝 솔루션의 보급은, 노령 인구의 증가와 거기에 따르는 치매, 알츠하이머병, 후기 우울증 등의 노화 관련 질환의 증가가 배경에 있습니다.

지역별로는 아시아태평양이 예측 기간 중 가장 높은 성장을 기록할 전망 :

환자 부담의 증가, 정신장애의 이환율 증가에 의한 정신건강 서비스의 이용 용이성 향상, 정신장애에 관한 인지도 향상을 위한 정부 구상의 증가 등의 요인이 이 지역의 시장 성장을 촉진할 것으로 예상되고 있습니다.

세계의 정신건강 스크리닝 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 기술·특허의 동향, 법규제·상환 환경, 사례 연구, 비즈니스 모델, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• 주요 업계 동향
• 가격 분석
• 가치/공급망 분석
• 에코시스템 분석
• Porter's Five Forces 분석
• 규제 상황
• 기술 분석
• 특허 분석
• 무역 분석
• 사례 연구 분석
• 주요 컨퍼런스와 이벤트
• 주요 이해관계자와 구입 기준
• 미충족 요구
• 고객의 비즈니스에 영향을 미치는 동향/디스럽션
• 상환 시나리오 분석
• 비즈니스 모델 분석
• 투자와 자금조달 시나리오

제6장 정신건강 스크리닝 시장 : 용도별

• 생리학적 장애
  • 우울증
  • 불안
  • 외상 후 스트레스 장애(PTSD)
  • 조울증
  • 섭식 장애
  • 약물 사용
  • 기타
• 정신장애
  • 정신분열증
  • 정신장애
  • 해리성 장애
  • 강박장애(OCD)
  • 주의력결핍 과잉행동장애(ADHD)
  • 기타
• 행동 장애
  • 자해
  • 공격성
  • 수면장애
  • 사회적 위축
  • 과잉행동
  • 기타
• 인지장애
  • 인식 기능 장애
  • 치매
  • 알츠하이머병
  • 기타

제7장 정신건강 스크리닝 시장 : 스크리닝 방법별

• 자기 보고 앙케이트·서베이
  • BDI
  • GAD-7
  • HAM-A
  • PHQ-12
  • Y-BOCS
  • 기타
• 임상 면접
  • MINI
  • SCID
  • DIPD
  • 기타
• 관찰에 기반한 평가
• 바이오마커 검사

제8장 정신건강 스크리닝 시장 : 기술별

• 셀프 스크리닝 모바일 헬스 앱
• 텔레헬스·가상 케어 솔루션
• 웨어러블 디바이스에 의한 계속 모니터링
• AI 기반 스크리닝 툴
• 원격 정신건강 플랫폼

제9장 정신건강 스크리닝 시장 : 연령별

• 소아·청소년(0-18세)
• 성인(19-64세)
• 고령자(65세 이상)

제10장 정신건강 스크리닝 시장 : 환경별

• 임상 현장
• 교육기관
• 직장/기업 프로그램
• 온라인 플랫폼
• 기타

제11장 정신건강 스크리닝 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제12장 경쟁 구도

• 개요
• 주요 기업의 전략
• 시장 TOP 기업 매출 점유율 분석(2022년)
• 시장 점유율 분석(2022)
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 중소기업/신규 기업
• 정신건강 검사 웨어러블 디바이스 벤더의 평가와 재무 지표
• 제품의 비교 분석
• 경쟁 시나리오

제13장 기업 개요

• 주요 기업
  • SONDERMIND(TOTAL BRAIN)
  • RIVERSIDE COMMUNITY CARE(MINDWISE INNOVATIONS)
  • PROEM BEHAVIORAL HEALTH
  • HEADSPACE HEALTH
  • QUARTET HEALTH, INC.
  • CLARIGENT HEALTH
  • ELLIPSIS HEALTH, INC.
  • ADAPTIVE TESTING TECHNOLOGIES
  • AIBERRY
  • KINTSUGI MINDFUL WELLNESS, INC.
  • THYMIA LIMITED
  • CANARY SPEECH, INC.
  • MODERN LIFE, INC.
  • SONDE HEALTH, INC.
  • FUTURESTHRIVE
  • KONINKLIJKE PHILIPS N.V.
  • ALPHABET INC.(FITBIT)
  • RESMED INC.
  • APPLE INC.
  • COGNITIVE HEALTH SOLUTIONS
• 기타 기업
  • WELLIN5 USA, INC.
  • MOODTOOLS
  • MOODFIT
  • COGNIABLE
  • WOEBOT LABS, INC.

제14장 부록

영문목차

The Mental Health Screening market is projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period. The rising awareness of mental health issues

due to the growing geriatric population and subsequent increase in prevalence of mental disorders, and increasing focus on remote monitoring are the factors that will drive the growth of this market. On the other hand, stigma and limited awareness, and data privacy concerns may impede the adoption of mental health screening solutions to a certain extent over the forecast period.

"AI-based Screening Tools is expected to register highest growth in the forecast period, by technology segment."

Based on technology, the Mental Health Screening market is segmented into self-screening mHealth apps, telehealth & virtual care solutions, continuous monitoring wearable devices, AI-based screening tools, and remote mental health platforms. The AI-based screening tools segment is projected to witness the highest growth rate during the forecast period. Growth in this market can be attributed to the increasing demand for scalable and accurate solutions in mental health screening, coupled with advancements in AI technology.

"Clinical settings segment is estimated to hold the largest share of Mental Health Screening market, by setting."

Based on setting, the global mental health screening market is segmented into clinical settings, educational institutions, workplace/corporate programs, online platforms, and other settings. The clinical settings segment accounted for the largest share of the mental health screening market in 2022. This segment is expected to witness significant growth due to increased awareness, the rising prevalence of mental health disorders, technological advancements, policy support, and a shift towards preventive and patient-centered care.

"The Seniors (age 65 and above) segment is expected to register highest growth in the forecast period, by age-group."

Based on age group, the mental health screening market is segmented into children & adolescents (age 0-18 years), adults (age 19-64 years), and seniors (age 65 and above). The seniors segment is projected to witness the highest growth rate during the forecast period. The growth of mental health screening solutions adoption among seniors is driven by the rising geriatric population and the subsequent increase in age-related conditions like dementia, Alzheimer's disease, and late-life depression.

"Asia Pacific to register the highest growth in the Mental Health Screening market in the forecast period."

The global Mental Health Screening market is segmented into four major regions, namely, North America, Europe, APAC, and the Rest of the World. In 2022, Asia Pacific was expected to register the highest growth for Mental Health Screening solutions in the forecast period. Factors such as increasing patient burden, improved accessibility of mental health services due to the growing incidence of mental disorders, and rising government initiatives for increasing awareness about mental disorders are expected to drive the growth of the Mental Health Screening market in the Asia Pacific.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:

• By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
• By Designation: C-level Executives (27%), Director-level (18%), and Managers (55%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and Middle East and Africa (2%)

The prominent players in mental health screening market are Adaptive Testing Technologies (US), Proem Behavioral Health (US), Aiberry (US), SonderMind Inc. (US), Clarigent Health (US), Riverside Community Care (US), Kintsugi Mindful Wellness, Inc. (US), Thymia Limited (UK), Ellipsis Health Inc. (US), Canary Speech, Inc. (US), Headspace Health (US), Quartet Health, Inc. (US), Modern Life, Inc. (US), Sonde Health, Inc. (US), FuturesTHRIVE (US), Koninklijke Philips N.V. (Netherlands), Alphabet Inc. (Fitbit) (US), ResMed (US), Apple Inc. (US), MoodFit (US), Wellin5 USA Inc. (Canada), MoodTools (US), Cognitive Health Solutions LLC (US), Woebot Labs Inc. (US), and CogniABle (India). Players adopted organic as well as inorganic growth strategies such as partnerships, acquisitions, and product launches to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

• The report studies the Mental Health Screening market based on application, screening method, technology, age group, setting, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Mental Health Screening market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

• Analysis of key drivers (growing geriatric population and subsequent increase in prevalence of mental disorders, rising awareness of mental health issues, technological advancements, increasing focus on remote monitoring), restraints (stigma and limited awareness, and Data privacy concerns), opportunities (integration with wearable technologies, and rise of social media and its impact on adoption of mental health screening tools) and challenge (Integration with wearable technologies).
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the Mental Health Screening market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of Mental Health Screening solutions across regions.
• Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the Mental Health Screening market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the Mental Health Screening market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • FIGURE 1 MENTAL HEALTH SCREENING MARKET SEGMENTATION
  • 1.3.2 REGIONAL SEGMENTATION
  • FIGURE 2 MENTAL HEALTH SCREENING MARKET: REGIONAL SEGMENTATION
  • 1.3.3 YEARS CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 CURRENCY CONSIDERED

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH APPROACH
  • FIGURE 3 RESEARCH APPROACH
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY DATA
  • FIGURE 4 PRIMARY SOURCES
    • 2.2.2.1 Key data from primary sources
    • 2.2.2.2 Key industry insights
    • 2.2.2.3 Breakdown of primaries
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.3 MARKET SIZE ESTIMATION
  • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 7 MENTAL HEALTH SCREENING MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR KONINKLIJKE PHILIPS
  • FIGURE 8 CAGR PROJECTIONS
  • FIGURE 9 IMPACT ON MARKET GROWTH AND CAGR: ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2029)
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
• 2.5 MARKET SHARE ESTIMATION
• 2.6 STUDY ASSUMPTIONS
• 2.7 LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS
• 2.8 RISK ASSESSMENT
  • TABLE 1 RISK ASSESSMENT: MENTAL HEALTH SCREENING MARKET
• 2.9 IMPACT OF RECESSION ON MENTAL HEALTH SCREENING MARKET

3 EXECUTIVE SUMMARY

• FIGURE 11 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)
• FIGURE 12 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2023 VS. 2029 (USD MILLION)
• FIGURE 13 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
• FIGURE 14 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2023 VS. 2029 (USD MILLION)
• FIGURE 15 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2023 VS. 2029 (USD MILLION)
• FIGURE 16 GEOGRAPHICAL SNAPSHOT OF MENTAL HEALTH SCREENING MARKET

4 PREMIUM INSIGHTS

• 4.1 MENTAL HEALTH SCREENING MARKET OVERVIEW
  • FIGURE 17 GROWING INCIDENCE OF MENTAL HEALTH DISORDERS TO DRIVE MARKET
• 4.2 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION AND COUNTRY (2022)
  • FIGURE 18 PHYSIOLOGICAL DISORDERS ACCOUNTED FOR LARGEST SHARE OF MENTAL HEALTH SCREENING MARKET IN 2022
• 4.3 MENTAL HEALTH SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• 4.4 MENTAL HEALTH SCREENING MARKET, BY REGION (2020-2027)
  • FIGURE 20 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD
• 4.5 MENTAL HEALTH SCREENING MARKET: DEVELOPED VS. EMERGING ECONOMIES
  • FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 22 MENTAL HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing geriatric population and subsequent increase in prevalence of mental disorders
    • 5.2.1.2 Rising awareness of mental health issues
    • 5.2.1.3 Technological advancements
    • 5.2.1.4 Increasing focus on remote monitoring
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Stigma and limited awareness
    • 5.2.2.2 Data privacy concerns
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Integration with wearable technologies
    • 5.2.3.2 Rise of social media and its impact on adoption of mental health screening tools
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Concerns regarding accuracy and validity
• 5.3 KEY INDUSTRY TRENDS
  • 5.3.1 INTEGRATION WITH PRIMARY CARE SETTINGS
  • 5.3.2 DIGITAL AND REMOTE SOLUTIONS
• 5.4 PRICING ANALYSIS
  • TABLE 2 AVERAGE SELLING PRICE TREND, BY REGION
  • TABLE 3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
• 5.5 VALUE/SUPPLY CHAIN ANALYSIS
  • 5.5.1 RESEARCH & DEVELOPMENT
  • 5.5.2 MANUFACTURING & PRODUCTION
  • 5.5.3 DISTRIBUTION
  • 5.5.4 MARKETING & SALES
  • 5.5.5 POST-SALES SERVICES
  • FIGURE 23 MENTAL HEALTH SCREENING MARKET: VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 PORTER'S FIVE FORCES ANALYSIS: MENTAL HEALTH SCREENING MARKET
  • 5.7.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7.2 BARGAINING POWER OF SUPPLIERS
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 THREAT OF NEW ENTRANTS
  • 5.7.5 THREAT OF SUBSTITUTES
• 5.8 REGULATORY LANDSCAPE
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.2 REGULATORY ANALYSIS
    • 5.8.2.1 North America
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
    • 5.8.2.4 Latin America
    • 5.8.2.5 Middle East & Africa
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 Artificial Intelligence (AI) & Machine Learning (ML)
    • 5.9.1.2 Telehealth platforms
    • 5.9.1.3 Mobile apps and platforms
  • 5.9.2 COMPLEMENTARY TECHNOLOGIES
    • 5.9.2.1 Electronic Health Records (EHRs)
    • 5.9.2.2 Chatbots and virtual assistants
  • 5.9.3 ADJACENT TECHNOLOGIES
    • 5.9.3.1 Genetic and biological markers
• 5.10 PATENT ANALYSIS
  • 5.10.1 PATENT PUBLICATION TRENDS FOR MENTAL HEALTH SCREENING
  • 5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES
  • FIGURE 24 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MENTAL HEALTH SCREENING PATENTS, 2012-2023
  • 5.10.3 MAJOR PATENTS IN MENTAL HEALTH SCREENING MARKET
  • FIGURE 25 MAJOR PATENTS FOR MENTAL HEALTH SCREENING SOLUTIONS (2012-2023)
  • 5.10.4 PATENTS FILED
• 5.11 TRADE ANALYSIS
  • FIGURE 26 PRODUCT EXPORTS UNDER HSN CODE: 9113, BY COUNTRY, 2022 (USD THOUSAND)
  • FIGURE 27 PRODUCT IMPORTS UNDER HSN CODE 9113, BY COUNTRY, 2022 (USD THOUSAND)
• 5.12 CASE STUDY ANALYSIS
  • TABLE 6 CASE STUDY 1: AIBERRY'S COLLABORATIVE CLINICAL STUDY WITH UNIVERSITY OF ARIZONA FOR AI-POWERED MENTAL HEALTH SCREENING PLATFORM
  • TABLE 7 CASE STUDY 2: IMPACT OF MINDWISE SCREENING PROGRAM AT HARVARD UNIVERSITY
• 5.13 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.13.1 LIST OF KEY CONFERENCES & EVENTS IN MENTAL HEALTH SCREENING MARKET, 2024-2025
• 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • TABLE 8 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MENTAL HEALTH SCREENING SOLUTIONS
  • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY
  • 5.14.2 BUYING CRITERIA
  • FIGURE 28 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY
  • TABLE 10 KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY
• 5.15 UNMET NEEDS
  • TABLE 11 UNMET NEEDS IN MENTAL HEALTH SCREENING MARKET
  • 5.15.1 END-USER EXPECTATIONS
  • TABLE 12 END-USER EXPECTATIONS IN MENTAL HEALTH SCREENING MARKET
• 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 29 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR MENTAL HEALTH SCREENING MARKET
• 5.17 REIMBURSEMENT SCENARIO ANALYSIS
  • TABLE 13 CPT CODES AND REIMBURSEMENT ANALYSIS IN MENTAL HEALTH SCREENING MARKET IN US
• 5.18 BUSINESS MODEL ANALYSIS
• 5.19 INVESTMENT & FUNDING SCENARIO
  • FIGURE 30 INVESTOR DEALS AND VC FUNDING OF US-BASED MENTAL HEALTH STARTUPS INCREASED IN 2020

6 MENTAL HEALTH SCREENING MARKET, BY APPLICATION

• 6.1 INTRODUCTION
  • TABLE 14 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 15 MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 6.2 PHYSIOLOGICAL DISORDERS
  • TABLE 16 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 17 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 18 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 19 MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.1 DEPRESSION
    • 6.2.1.1 Increased adoption of depression screening to drive market
  • TABLE 20 MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 21 MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.2 ANXIETY
    • 6.2.2.1 Increasing burden of anxiety disorders & rising awareness to fuel market growth
  • TABLE 22 MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 23 MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.3 POST-TRAUMATIC STRESS DISORDER (PTSD)
    • 6.2.3.1 Rising number of initiatives for PTSD to propel market
  • TABLE 24 MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 25 MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.4 BIPOLAR DISORDER
    • 6.2.4.1 Growing public awareness to drive bipolar disorder screening uptake
  • TABLE 26 MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 27 MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.5 EATING DISORDER
    • 6.2.5.1 Increasing incidence and hospital visits to drive adoption of eating disorder screening
  • FIGURE 31 GLOBAL EATING DISORDER PREVALENCE, BY AGE, 2015-2019
  • TABLE 28 MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 29 MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.6 SUBSTANCE USE
    • 6.2.6.1 Increasing cases of substance use to drive market
  • TABLE 30 MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 31 MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.7 OTHER PHYSIOLOGICAL DISORDERS
  • TABLE 32 MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 33 MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3 PSYCHIATRIC DISORDERS
  • TABLE 34 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 35 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 36 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 37 MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.1 SCHIZOPHRENIA
    • 6.3.1.1 Advancements in screening tools for schizophrenia to support growth
  • TABLE 38 MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 39 MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.2 PSYCHOTIC DISORDER
    • 6.3.2.1 Increasing need for screening tools for early detection to drive market growth
  • TABLE 40 MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 41 MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3 DISSOCIATIVE DISORDER
    • 6.3.3.1 Growing awareness and education through screening and content creation to favor market growth
  • TABLE 42 MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 43 MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.4 OBSESSIVE COMPULSIVE DISORDER (OCD)
    • 6.3.4.1 Advancements in assessment tools to support market growth
  • TABLE 44 MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 45 MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.5 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
    • 6.3.5.1 Increasing cases & diagnosis to contribute to increased demand for ADHD screening
  • TABLE 46 MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 47 MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.6 OTHER PSYCHIATRIC DISORDERS
  • TABLE 48 MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 49 MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.4 BEHAVIORAL DISORDERS
  • TABLE 50 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 51 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 52 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 53 MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.1 SELF-HARM
    • 6.4.1.1 Advancements in screening technologies to drive awareness and growth in self-harm screening market
  • TABLE 54 MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 55 MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.2 AGGRESSION
    • 6.4.2.1 Rising cases of workplace aggression to propel demand for aggression screening
  • TABLE 56 MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 57 MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.3 SLEEP DISORDERS
    • 6.4.3.1 Increased stress and unhealthy lifestyles among adults to drive market
  • TABLE 58 MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 59 MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.4 SOCIAL WITHDRAWAL
    • 6.4.4.1 Increasing adolescent loneliness to drive demand for social withdrawal screening
  • TABLE 60 MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 61 MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.5 HYPERACTIVITY
    • 6.4.5.1 Increased awareness and recognition to drive growth
  • TABLE 62 MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 63 MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.6 OTHER BEHAVIORAL DISORDERS
  • TABLE 64 MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 65 MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.5 COGNITIVE DISORDERS
  • TABLE 66 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 67 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 69 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.5.1 COGNITIVE IMPAIRMENT
    • 6.5.1.1 Growing geriatric population and rising incidence of neurodegenerative disorders to support market growth
  • TABLE 70 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 71 MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.5.2 DEMENTIA
    • 6.5.2.1 Rising initiatives to promote dementia screening awareness to fuel market
  • TABLE 72 MENTAL HEALTH SCREENING MARKET FOR DEMENTIA, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 73 MENTAL HEALTH SCREENING MARKET FOR DEMENTIA FOR, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.5.3 ALZHEIMER'S DISEASE
    • 6.5.3.1 Favorable initiatives and increased access to screening to drive market
  • TABLE 74 MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER'S DISEASE, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 75 MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER'S DISEASE, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.5.4 OTHER COGNITIVE DISORDERS
  • TABLE 76 MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 77 MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)

7 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD

• 7.1 INTRODUCTION
  • TABLE 78 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 79 MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
• 7.2 SELF-REPORTED QUESTIONNAIRES & SURVEYS
  • TABLE 80 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 81 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 82 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 83 MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.1 BECK DEPRESSION INVENTORY (BDI)
    • 7.2.1.1 Increasing prevalence of depression to drive demand for BDI
  • TABLE 84 MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 85 MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.2 GENERALIZED ANXIETY DISORDER-7 (GAD-7)
    • 7.2.2.1 Growing concerns regarding anxiety disorders in adults to boost market
  • TABLE 86 MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 87 MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.3 HAMILTON ANXIETY RATING SCALE (HAM-A)
    • 7.2.3.1 Increasing demand for standardized & reliable assessment tools to favor market growth
  • TABLE 88 MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 89 MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.4 PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12)
    • 7.2.4.1 Growing focus on early intervention to boost demand
  • TABLE 90 MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 91 MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.5 YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS)
    • 7.2.5.1 Rising awareness of obsessive compulsive disorder (OCD) to fuel growth
  • TABLE 92 MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 93 MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.2.6 OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS
  • TABLE 94 MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 95 MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.3 CLINICAL INTERVIEWS
  • TABLE 96 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 97 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 99 MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3.1 MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI)
    • 7.3.1.1 Increasing global burden of psychiatric disorders to boost market growth
  • TABLE 100 MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 101 MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3.2 STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID)
    • 7.3.2.1 Growing demand for comprehensive & detail assessment screening methods to favor market growth
  • TABLE 102 MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 103 MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3.3 DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD)
    • 7.3.3.1 Increasing prevalence of psychological distress post pandemic to drive demand for DIPD
  • TABLE 104 MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 105 MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3.4 OTHER CLINICAL INTERVIEWS
  • TABLE 106 MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 107 MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.4 OBSERVATION-BASED ASSESSMENTS
  • 7.4.1 ADVANCES IN WEARABLE TECHNOLOGIES TO REVOLUTIONIZE OBSERVATION-BASED ASSESSMENT TOOLS
  • TABLE 108 MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 109 MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.5 BIOMARKER TESTING
  • 7.5.1 ADVANCES IN ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO DRIVE ADOPTION OF BIOMARKER TESTING TECHNOLOGIES
  • TABLE 110 MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 111 MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2022-2029 (USD MILLION)

8 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY

• 8.1 INTRODUCTION
  • TABLE 112 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 113 MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• 8.2 SELF-SCREENING MHEALTH APPS
  • 8.2.1 INCREASING AWARENESS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF MHEALTH APPS IN FUTURE
  • TABLE 114 MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 115 MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.3 TELEHEALTH & VIRTUAL CARE SOLUTIONS
  • 8.3.1 RISING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE SERVICES TO FUEL MARKET GROWTH
  • TABLE 116 MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 117 MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.4 CONTINUOUS MONITORING WEARABLE DEVICES
  • 8.4.1 SHIFT TOWARDS PROACTIVE AND PERSONALIZED HEALTHCARE TO DRIVE MARKET GROWTH
  • TABLE 118 MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 119 MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.5 AI-BASED SCREENING TOOLS
  • 8.5.1 HIGH COST ASSOCIATED WITH AI-BASED SCREENING TOOLS TO RESTRAIN MARKET GROWTH
  • TABLE 120 MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 121 MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.6 REMOTE MENTAL HEALTH PLATFORMS
  • 8.6.1 INCREASED ADOPTION OF REMOTE MENTAL HEALTH SCREENING PLATFORMS TO FAVOR MARKET GROWTH
  • TABLE 122 MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 123 MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2022-2029 (USD MILLION)

9 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP

• 9.1 INTRODUCTION
  • TABLE 124 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 125 MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• 9.2 CHILDREN & ADOLESCENTS (AGE 0-18 YEARS)
  • 9.2.1 GROWING PREVALENCE OF MENTAL HEALTH DISORDERS IN CHILDREN & ADOLESCENTS TO DRIVE MARKET GROWTH
  • TABLE 126 MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0-18 YEARS), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 127 MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0-18 YEARS), BY COUNTRY, 2022-2029 (USD MILLION)
• 9.3 ADULTS (AGE 19-64 YEARS)
  • 9.3.1 GROWING POPULARITY OF WORKPLACE WELLNESS PROGRAMS TO BOOST DEMAND FOR MENTAL HEALTH SCREENING
  • TABLE 128 MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19-64 YEARS), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 129 MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19-64 YEARS), BY COUNTRY, 2022-2029 (USD MILLION)
• 9.4 SENIORS (AGE 65 AND ABOVE)
  • 9.4.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN AGE-RELATED MENTAL DISORDERS TO BOOST MARKET
  • TABLE 130 MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 131 MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2022-2029 (USD MILLION)

10 MENTAL HEALTH SCREENING MARKET, BY SETTING

• 10.1 INTRODUCTION
  • TABLE 132 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 133 MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
• 10.2 CLINICAL SETTINGS
  • 10.2.1 SHIFT TOWARDS PREVENTIVE AND PATIENT-CENTRED CARE TO DRIVE MARKET GROWTH
  • TABLE 134 MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 135 MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
• 10.3 EDUCATIONAL INSTITUTIONS
  • 10.3.1 GROWING INITIATIVES TO BOOST GROWTH
  • TABLE 136 MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 137 MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• 10.4 WORKPLACE/CORPORATE PROGRAMS
  • 10.4.1 RISING MENTAL HEALTH CHALLENGES AND DUTY OF CARE TO DRIVE MARKET GROWTH
  • TABLE 138 MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 139 MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2022-2029 (USD MILLION)
• 10.5 ONLINE PLATFORMS
  • 10.5.1 ACCESSIBLE AND PERSONALIZED ASSESSMENTS TO DRIVE DEMAND
  • TABLE 140 MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 141 MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2022-2029 (USD MILLION)
• 10.6 OTHER SETTINGS
  • TABLE 142 MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 143 MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)

11 MENTAL HEALTH SCREENING MARKET, BY REGION

• 11.1 INTRODUCTION
  • TABLE 144 MENTAL HEALTH SCREENING MARKET, BY REGION, 2018-2021 (USD MILLION)
  • TABLE 145 MENTAL HEALTH SCREENING MARKET, BY REGION, 2022-2029 (USD MILLION)
• 11.2 NORTH AMERICA
  • FIGURE 32 NORTH AMERICA: MARKET SNAPSHOT
  • TABLE 146 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 147 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 149 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 150 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 151 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 153 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 155 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 157 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 159 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 160 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 161 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 163 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 165 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 166 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 167 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 168 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 169 NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.2.1 NORTH AMERICA: RECESSION IMPACT
  • 11.2.2 US
    • 11.2.2.1 US to dominate North American mental health screening market
  • TABLE 170 US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 171 US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 172 US: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 173 US: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 US: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 175 US: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 US: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 177 US: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 US: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 179 US: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 US: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 181 US: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 182 US: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 183 US: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 US: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 185 US: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 US: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 187 US: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 188 US: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 189 US: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 190 US: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 191 US: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.2.3 CANADA
    • 11.2.3.1 Growing investments in mental health and well-being to contribute to market growth
  • TABLE 192 CANADA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 193 CANADA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 194 CANADA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 195 CANADA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 CANADA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 197 CANADA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 CANADA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 199 CANADA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 CANADA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 201 CANADA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 CANADA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 203 CANADA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 204 CANADA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 205 CANADA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 CANADA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 207 CANADA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 CANADA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 209 CANADA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 210 CANADA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 211 CANADA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 212 CANADA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 213 CANADA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
• 11.3 EUROPE
  • TABLE 214 EUROPE: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 215 EUROPE: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 217 EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 218 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 219 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 221 EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 223 EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 225 EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 227 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 228 EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 229 EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 231 EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 233 EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 234 EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 235 EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 236 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 237 EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.3.1 EUROPE: RECESSION IMPACT
  • 11.3.2 UK
    • 11.3.2.1 Long waiting periods and inadequate access to care to favor market growth
  • TABLE 238 UK: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 239 UK: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 240 UK: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 241 UK: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 UK: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 243 UK: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 UK: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 245 UK: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 UK: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 247 UK: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 UK: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 249 UK: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 250 UK: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 251 UK: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 UK: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 253 UK: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 UK: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 255 UK: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 256 UK: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 257 UK: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 258 UK: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 259 UK: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.3.3 GERMANY
    • 11.3.3.1 Large patient base and growing burden on health providers to drive demand for HCIT solutions
  • TABLE 260 GERMANY: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 261 GERMANY: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 262 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 263 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 265 GERMANY: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 GERMANY: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 267 GERMANY: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 GERMANY: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 269 GERMANY: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 271 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 272 GERMANY: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 273 GERMANY: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 GERMANY: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 275 GERMANY: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 GERMANY: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 277 GERMANY: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 278 GERMANY: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 279 GERMANY: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 280 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 281 GERMANY: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.3.4 FRANCE
    • 11.3.4.1 High prevalence of behavioral disorders to drive support for implementing mental health screening solutions in France
  • TABLE 282 FRANCE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 283 FRANCE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 284 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 285 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 287 FRANCE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 FRANCE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 289 FRANCE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 FRANCE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 291 FRANCE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 293 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 294 FRANCE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 295 FRANCE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 296 FRANCE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 297 FRANCE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 FRANCE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 299 FRANCE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 300 FRANCE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 301 FRANCE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 302 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 303 FRANCE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.3.5 REST OF EUROPE
  • TABLE 304 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 305 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 306 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 307 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 308 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 309 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 311 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 313 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 314 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 315 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 316 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 317 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 319 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 321 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 322 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 323 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 324 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 325 REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
• 11.4 ASIA PACIFIC
  • FIGURE 33 ASIA PACIFIC: MARKET SNAPSHOT
  • TABLE 326 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 327 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 328 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 329 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 330 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 333 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 334 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 335 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 337 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 340 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 341 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 342 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 343 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 344 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 345 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 348 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 349 ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
  • 11.4.2 CHINA
    • 11.4.2.1 Rising incidence of mental illnesses to drive demand for care solutions in China
  • TABLE 350 CHINA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 351 CHINA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 352 CHINA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 353 CHINA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 354 CHINA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 355 CHINA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 356 CHINA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 357 CHINA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 358 CHINA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 359 CHINA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 360 CHINA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 361 CHINA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 362 CHINA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 363 CHINA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 364 CHINA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 365 CHINA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 366 CHINA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 367 CHINA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 368 CHINA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 369 CHINA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 370 CHINA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 371 CHINA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.4.3 JAPAN
    • 11.4.3.1 Rising geriatric population in Japan and subsequent increase in age-related mental disorders to boost market
  • TABLE 372 JAPAN: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 373 JAPAN: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 374 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 375 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 376 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 377 JAPAN: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 378 JAPAN: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 379 JAPAN: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 380 JAPAN: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 381 JAPAN: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 382 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 383 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 384 JAPAN: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 385 JAPAN: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 386 JAPAN: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 387 JAPAN: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 388 JAPAN: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 389 JAPAN: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 390 JAPAN: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 391 JAPAN: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 392 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 393 JAPAN: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.4.4 INDIA
    • 11.4.4.1 Inadequate workforce and lack of access to drive adoption of solutions
  • TABLE 394 INDIA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 395 INDIA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 396 INDIA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 397 INDIA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 398 INDIA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 399 INDIA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 400 INDIA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 401 INDIA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 402 INDIA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 403 INDIA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 404 INDIA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 405 INDIA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 406 INDIA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 407 INDIA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 408 INDIA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 409 INDIA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 410 INDIA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 411 INDIA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 412 INDIA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 413 INDIA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 414 INDIA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 415 INDIA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)

• 11.4.5 REST OF ASIA PACIFIC
• TABLE 416 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
• TABLE 417 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 418 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
• TABLE 419 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 420 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
• TABLE 421 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 422 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
• TABLE 423 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 424 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
• TABLE 425 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 426 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
• TABLE 427 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
• TABLE 428 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
• TABLE 429 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 430 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
• TABLE 431 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 432 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
• TABLE 433 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
• TABLE 434 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
• TABLE 435 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
• TABLE 436 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
• TABLE 437 REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
• 11.5 LATIN AMERICA
  • TABLE 438 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 439 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 440 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 441 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 442 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 443 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 444 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 445 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 446 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 447 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 448 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 449 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 450 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 451 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 452 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 453 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 454 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 455 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 457 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 458 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 459 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 460 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 461 LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.5.1 LATIN AMERICA: RECESSION IMPACT
  • 11.5.2 BRAZIL
    • 11.5.2.1 Large healthcare industry and increased investments in healthcare to boost market
  • TABLE 462 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 463 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 464 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 465 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 466 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 467 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 468 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 469 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 470 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 471 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 472 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 473 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 474 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 475 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 476 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 477 BRAZIL: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 478 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 479 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 480 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 481 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 482 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 483 BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.5.3 MEXICO
    • 11.5.3.1 Growing number of mental health patients to drive market
  • TABLE 484 MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 485 MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 486 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 487 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 488 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 489 MEXICO: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 490 MEXICO: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 491 MEXICO: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 492 MEXICO: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 493 MEXICO: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 494 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 495 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 496 MEXICO: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 497 MEXICO: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 498 MEXICO: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 499 MEXICO: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 500 MEXICO: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 501 MEXICO: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 502 MEXICO: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 503 MEXICO: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 504 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 505 MEXICO: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.5.4 REST OF LATIN AMERICA
  • TABLE 506 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 507 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 508 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 509 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 510 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 511 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 512 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 513 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 514 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 515 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 516 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 517 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 518 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 519 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 520 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 521 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 522 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 523 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 524 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 525 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 526 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 527 REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
• 11.6 MIDDLE EAST & AFRICA
  • TABLE 528 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018-2021 (USD MILLION)
  • TABLE 529 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 530 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 531 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 532 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 533 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 534 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 535 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 536 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 537 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 538 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 539 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 540 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 541 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 542 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 543 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 544 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 545 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 546 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 547 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 548 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 549 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 550 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 551 MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Growing initiatives to address mental health issues to drive growth
  • TABLE 552 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 553 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 554 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 555 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 556 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 557 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 558 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 559 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 560 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 561 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 562 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 563 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 564 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 565 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 566 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 567 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 568 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 569 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 570 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 571 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 572 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 573 GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)
  • 11.6.3 REST OF MIDDLE EAST & AFRICA
  • TABLE 574 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018-2021 (USD MILLION)
  • TABLE 575 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 576 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 577 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 578 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 579 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 580 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 581 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 582 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 583 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 584 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018-2021 (USD MILLION)
  • TABLE 585 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022-2029 (USD MILLION)
  • TABLE 586 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 587 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 588 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018-2021 (USD MILLION)
  • TABLE 589 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 590 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018-2021 (USD MILLION)
  • TABLE 591 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 592 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018-2021 (USD MILLION)
  • TABLE 593 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 594 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018-2021 (USD MILLION)
  • TABLE 595 REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022-2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • FIGURE 34 MENTAL HEALTH SCREENING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
• 12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (2022)
  • FIGURE 35 MENTAL HEALTH SCREENING MARKET: REVENUE ANALYSIS FOR KEY PLAYERS, 2018-2022
• 12.4 MARKET SHARE ANALYSIS (2022)
  • 12.4.1 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET (2022)
  • FIGURE 36 MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: MARKET SHARE ANALYSIS FOR KEY PLAYERS, 2022
  • TABLE 596 MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: DEGREE OF COMPETITION
  • 12.4.2 MARKET RANKING ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING MARKET (2022)
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 PERVASIVE PLAYERS
  • 12.5.3 EMERGING LEADERS
  • 12.5.4 PARTICIPANTS
  • FIGURE 37 MENTAL HEALTH SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  • FIGURE 38 MENTAL HEALTH SCREENING MARKET: COMPANY FOOTPRINT
  • TABLE 597 MENTAL HEALTH SCREENING MARKET: REGION FOOTPRINT
  • TABLE 598 MENTAL HEALTH SCREENING MARKET: APPLICATION FOOTPRINT
  • TABLE 599 MENTAL HEALTH SCREENING MARKET: SCREENING METHOD FOOTPRINT
  • TABLE 600 MENTAL HEALTH SCREENING MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 601 MENTAL HEALTH SCREENING MARKET: AGE GROUP FOOTPRINT
• 12.6 COMPANY EVALUATION MATRIX: SMES/STARTUPS, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 DYNAMIC COMPANIES
  • 12.6.3 RESPONSIVE COMPANIES
  • 12.6.4 STARTING BLOCKS
  • FIGURE 39 MENTAL HEALTH SCREENING MARKET: COMPANY EVALUATION MATRIX (SMES/START-UPS), 2023
  • 12.6.5 COMPETITIVE BENCHMARKING: SMES/STARTUPS, 2023
  • TABLE 602 MENTAL HEALTH SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 603 MENTAL HEALTH SCREENING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/ SME PLAYERS
• 12.7 VALUATION AND FINANCIAL METRICS OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS
  • FIGURE 40 MENTAL HEALTH SCREENING MARKET: EV/EBITDA OF KEY VENDORS
  • FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS
• 12.8 PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 42 MENTAL HEALTH SCREENING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SCREENING METHOD
  • 12.8.1 TOTAL BRAIN PLATFORM
  • 12.8.2 AIBERRY MENTAL HEALTH ASSESSMENT & SCREENING
  • 12.8.3 HEADSPACE FOR WORK
  • 12.8.4 QUARTET
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 MENTAL HEALTH SCREENING MARKET: PRODUCT LAUNCHES
  • TABLE 604 MENTAL HEALTH SCREENING MARKET: PRODUCT LAUNCHES
  • 12.9.2 MENTAL HEALTH SCREENING MARKET: DEALS
  • TABLE 605 MENTAL HEALTH SCREENING MARKET: DEALS
  • 12.9.3 MENTAL HEALTH SCREENING MARKET: OTHER DEVELOPMENTS
  • TABLE 606 MENTAL HEALTH SCREENING MARKET: OTHER DEVELOPMENTS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
• (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 13.1.1 SONDERMIND (TOTAL BRAIN)
• TABLE 607 SONDERMIND: COMPANY OVERVIEW
• TABLE 608 SONDERMIND: DEALS
• TABLE 609 SONDERMIND: EXPANSIONS
• 13.1.2 RIVERSIDE COMMUNITY CARE (MINDWISE INNOVATIONS)
• TABLE 610 RIVERSIDE COMMUNITY CARE: COMPANY OVERVIEW
• 13.1.3 PROEM BEHAVIORAL HEALTH
• TABLE 611 PROEM BEHAVIORAL HEALTH: COMPANY OVERVIEW
• TABLE 612 PROEM BEHAVIORAL HEALTH: DEALS
• TABLE 613 PROEM BEHAVIORAL HEALTH: OTHER DEVELOPMENTS
• 13.1.4 HEADSPACE HEALTH
• TABLE 614 HEADSPACE HEALTH: COMPANY OVERVIEW
• 13.1.5 QUARTET HEALTH, INC.
• TABLE 615 QUARTET HEALTH, INC.: COMPANY OVERVIEW
• TABLE 616 QUARTET HEALTH, INC.: DEALS
• 13.1.6 CLARIGENT HEALTH
• TABLE 617 CLARIGENT HEALTH: COMPANY OVERVIEW
• TABLE 618 CLARIGENT HEALTH: PRODUCT LAUNCHES
• TABLE 619 CLARIGENT HEALTH: DEALS
• 13.1.7 ELLIPSIS HEALTH, INC.
• TABLE 620 ELLIPSIS HEALTH: COMPANY OVERVIEW
• TABLE 621 ELLIPSIS HEALTH, INC.: DEALS
• 13.1.8 ADAPTIVE TESTING TECHNOLOGIES
• TABLE 622 ADAPTIVE TESTING TECHNOLOGIES: COMPANY OVERVIEW
• 13.1.9 AIBERRY
• TABLE 623 AIBERRY: COMPANY OVERVIEW
• TABLE 624 AIBERRY: PRODUCT ENHANCEMENTS
• 13.1.10 KINTSUGI MINDFUL WELLNESS, INC.
• TABLE 625 KINTSUGI MINDFUL WELLNESS, INC.: COMPANY OVERVIEW
• 13.1.11 THYMIA LIMITED
• TABLE 626 THYMIA LIMITED: COMPANY OVERVIEW
• 13.1.12 CANARY SPEECH, INC.
• TABLE 627 CANARY SPEECH, INC.: COMPANY OVERVIEW
• TABLE 628 CANARY SPEECH, INC.: DEALS
• 13.1.13 MODERN LIFE, INC.
• TABLE 629 MODERN LIFE, INC.: COMPANY OVERVIEW
• 13.1.14 SONDE HEALTH, INC.
• TABLE 630 SONDE HEALTH, INC.: COMPANY OVERVIEW
• TABLE 631 SONDE HEALTH, INC.: PRODUCT LAUNCHES
• TABLE 632 SONDE HEALTH, INC.: DEALS
• 13.1.15 FUTURESTHRIVE
• TABLE 633 FUTURESTHRIVE: COMPANY OVERVIEW
• 13.1.16 KONINKLIJKE PHILIPS N.V.
• TABLE 634 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
• FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
• TABLE 635 KONINKLIJKE PHILIPS N.V.: DEALS
• 13.1.17 ALPHABET INC. (FITBIT)
• TABLE 636 ALPHABET INC.: COMPANY OVERVIEW
• FIGURE 44 ALPHABET INC.: COMPANY SNAPSHOT (2022)
• TABLE 637 ALPHABET INC.: PRODUCT LAUNCHES & APPROVALS
• TABLE 638 ALPHABET INC.: DEALS
• 13.1.18 RESMED INC.
• TABLE 639 RESMED INC.: COMPANY OVERVIEW
• FIGURE 45 RESMED INC.: COMPANY SNAPSHOT (2023)
• TABLE 640 RESMED INC.: PRODUCT LAUNCHES
• TABLE 641 RESMED INC.: DEALS
• 13.1.19 APPLE INC.
• TABLE 642 APPLE INC.: COMPANY OVERVIEW
• FIGURE 46 APPLE INC.: COMPANY SNAPSHOT (2023)
• TABLE 643 APPLE INC.: PRODUCT LAUNCHES
• 13.1.20 COGNITIVE HEALTH SOLUTIONS
• TABLE 644 COGNITIVE HEALTH SOLUTIONS: COMPANY OVERVIEW
• 13.2 OTHER PLAYERS
  • 13.2.1 WELLIN5 USA, INC.
  • 13.2.2 MOODTOOLS
  • 13.2.3 MOODFIT
  • 13.2.4 COGNIABLE
  • 13.2.5 WOEBOT LABS, INC.
• *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS